The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and Pfizer's PFE.N Abrysvo.

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...

“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

The Centers for Disease Control and Prevention (CDC) recommends that pregnant women receive an RSV vaccine during their third ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, months before they were abruptly fired by U.S. Health Secretary Robert F ...

“These vaccines provide an opportunity to help protect older adults against severe RSV illness at a time when multiple respiratory infections are likely to circulate,” the CDC said in a statement.

The first vaccines to guard against the respiratory illness RSV will soon be available for some older adults, ages 60 and over, after the CDC formally backed recommendations for the shots.

CDC recommends RSV vaccine for pregnant women ahead of virus season. Updated September 23, 2023. 4 min. The CDC has recommended that expectant mothers get an RSV vaccine if they are between 32 and ...

RSV also strikes late in life, causing more than 177,000 hospitalizations and 14,000 deaths among older adults each year. Trial data showed Arexvy, developed by GSK, was 82% effective at ...

A CDC advisory committee recommended approval of an RSV vaccine for adults aged 60 and older. What this means for a potential fall rollout.

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the use of respiratory syncytial virus vaccines in adults aged between 50 and 59 ...